Table 1 Characteristics of the studies included in the meta-analysis
Study/Year | Area/Design | Type of surgery | Time of recruitment | Criteria of AKI | n, M/F (%) | Age | AKI (%) |
|---|---|---|---|---|---|---|---|
Amini, S 2017 | Iran/PCS | CS for CHD | 2013.03–2016.02 | pRIFLE | 519, 49.9/50.1 | < 18 years | 150 (28.9) |
Aydin, SI 2012 | USA/RCS | CS for CHD | 2006.01–2009.11 | pRIFLE | 458, 52.4/47.6 | < 18 years | 234 (51.1) |
|  |  |  |  |  | 87, 52.9/47.1 | < 1 month | 53 (60.9) |
|  |  |  |  |  | 371, 52.3/47.7 | 1 month-18 years | 181 (48.8) |
Blinder, JJ 2017 | USA/RCS | CS for CHD | 2006.09–2012.05 | AKIN | 799, 53.8/46.2 | 0–36 ms | 289 (36.2) |
Fuhrman, DY 2019 | USA/RCS | CS for CHD | 2004.01–2015.12 | KDIGO | 699, 56.4/43.6 | 18–40 years | 92 (13.2) |
Garcia, RU 2020 | USA/RCS | CS for CHD with CPB | 2012.01–2017.12 | pRIFLE | 149, 65.1/34.9 | 14.9 (12.7–16.9) years | 4 (2.7) |
Gil-Ruiz Gil-Esparza 2014 | Spain/RCS | CS for CHD with CPB | 2008.01–2010.12 | pRIFLE | 409, 60.4/39.6 | 1 month-18 years | 107 (26.2) |
Hirano, D 2017 | Japan/RCS | CS for CHD | 2007.04–2013.08 | pRIFLE | 418, 62.0/38.0 | 5.0 (2.0–19.0) months | 104 (24.9) |
Huggins, N 2014 | USA/RCS | CS for CHD | 2007.01–2010.11 | AKIN | 113, NR/NR | < 18 years | 46 (40.7) |
Joffe, R 2018 | Canada/PCS | CS for CHD with CPB | 2013–2015 | KDIGO | 66, 51.5/48.5 | 5.9 (4.6–11.5) months | 43 (65.2) |
Kim, J 2020 | USA/RCS | CS for CHD with CPB | 2013.04–2018.05 | AKIN | 123, 49.6/50.4 | ≥18 years | 52 (42.3) |
Kimura, S 2018 | Japan/RCS | CS for CHD with CPB | 2013.12–2017.01 | KDIGO | 521, 53.4/46.6 | < 72 months | 205 (39.3) |
Kumar, TK 2016 | USA/RCS | CS for CHD with CPB | 2010.01–2012.12 | AKIN | 102, 55.9/44.1 | < 2 months | 11 (10.8) |
Kwiatkowski, DM 2017 | USA/RCS | CS for CHD with CPB | 2010.01–2013.12 | KDIGO | 118, 50.0/50.0 | 29 (21–39) years | 42 (35.6) |
Lee, SH 2017 | Korea/RCS | CS for CHD with CPB | 2011.04–2011.12 | pRIFLE | 135, 51.1/48.9 | < 18 years | 19 (14.1) |
|  |  |  |  |  | 13, NR/NR | < 1 month | 4 (30.8) |
|  |  |  |  |  | 122, NR/NR | 1 month-18 years | 15 (12.3) |
Li, S 2011 | USA/PCS | CS for CHD | 2007.07–2009.12 | AKIN | 311, 55.0/45.0 | 1 month-18 years | 130 (41.8) |
Madsen, NL 2017 | Denmark/PCS | CS for CHD | 1990.01–2010.12 | KDIGO | 382, 57.1/42.9 | < 14 years | 127 (33.2) |
Mah, KE 2018 | USA/RCS | CS for CHD | 2010.10–2012.12 | KDIGO | 117, 59.8/40.2 | < 30 days | 66 (56.4) |
Meersch, M 2014 | Germany/PCS | CS for CHD with CPB | 2013.07–2013.12 | pRIFLE | 51, 72.5/27.5 | < 18 years | 12 (23.5) |
Miklaszewska, M 2013 | Poland/PCS | CS for CHD with CPB | 2006–2009 | pRIFLE | 47, 51.1/48.9 | 0.5–204 months | 19 (40.4) |
Park, SK 2016 | Korea/RCS | CS for CHD | 2012.01–2012.12 | KDIGO | 220, 55/45 | 10 days-18 years | 92 (41.8) |
|  |  |  |  |  | 60, NR/NR | < 1 month | 29 (48.3) |
|  |  |  |  |  | 160, NR/NR | 1 month-18 years | 63 (39.4) |
Piggott, KD 2015 | USA/RCS | CS for CHD | 2010.05–2013.12 | AKIN | 95, 50.5/49.5 | < 1 month | 43 (45.3) |
Ricci, Z 2012 | Italy/PCS | CS for CHD with CPB | 2010.06–2011.06 | pRIFLE | 160, 55/45 | < 1 years | 90 (56.3) |
Ruf, B 2015 | Germany/PCS | CS for CHD with CPB | 2011.01–2011.08 | pRIFLE | 59, 59.3/40.7 | < 1 years | 28 (47.5) |
Sugimoto, K 2016 | Japan/PCS | CS for CHD with CPB | 2010.07–2012.07 | pRIFLE | 376, 58/42 | 1 month-18 years | 243 (64.6) |
Tanyildiz, M 2017 | Turkey/RCS | CS for CHD | 2009.01–2011.10 | pRIFLE | 137, 53.3/46.7 | 1 month-18 years | 84 (61.3) |
Taylor, ML 2013 | USA/RCS | CS for CHD | 2009.01–2009.12 | AKIN | 693, 53/47 | 6 days-18 years | 104 (15) |
Toth, R 2012 | Hungary/RCS | CS for CHD | 2004.01–2008.12 | pRIFLE | 1510, NR/NR | < 18 years | 481 (31.9) |
Ueno, K 2020 | Japan/RCS | CS for CHD | 2010.05–2018.01 | KDIGO | 81, 60.5/39.5 | < 1 month | 57 (70.4) |
Van Driest, SL2018 | USA/RCS | CS for CHD | 2008.07–2016.06 | KDIGO | 999, 50.0/50.0 | 1 month-18 years | 503 (50.4) |
Zheng, J 2013 | China/PCS | CS for CHD with CPB | 2010.11–2011.04 | AKIN | 693, 53/47 | < 3 years | 104 (15) |